HEADER STRUCTURAL PROTEIN 29-JUN-18 6A6P TITLE CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA TITLE 2 (PPARD)LBD IN COMPLEX WITH DN003316 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-DELTA,NUCI,NUCLEAR HORMONE RECEPTOR 1,NUC1,NUCLEAR COMPND 5 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2,PEROXISOME PROLIFERATOR- COMPND 6 ACTIVATED RECEPTOR BETA,PPAR-BETA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PPARDELTA, COMPLEX, NUCLEAR RECEPTOR, PEROXISOME PROLIFERATOR- KEYWDS 2 ACTIVATED RECEPTOR FAMILY, LIGAND BINDING DOMAIN (LBD), STRUCTURAL KEYWDS 3 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.W.CHIN,S.J.CHO,J.Y.SONG,J.H.HA REVDAT 3 22-NOV-23 6A6P 1 HETSYN REVDAT 2 29-JUL-20 6A6P 1 COMPND REMARK HETNAM SITE REVDAT 2 2 1 ATOM REVDAT 1 10-JUL-19 6A6P 0 JRNL AUTH J.W.CHIN,S.J.CHO,J.Y.SONG,J.H.HA JRNL TITL CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED JRNL TITL 2 RECEPTOR DELTA (PPARD)LBD IN COMPLEX WITH DN003316 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 41144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 2025 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.2071 - 5.0577 1.00 2913 134 0.1766 0.1824 REMARK 3 2 5.0577 - 4.0158 1.00 2847 142 0.1540 0.1890 REMARK 3 3 4.0158 - 3.5086 1.00 2879 148 0.1742 0.2084 REMARK 3 4 3.5086 - 3.1880 1.00 2862 119 0.1986 0.2499 REMARK 3 5 3.1880 - 2.9596 1.00 2826 147 0.2134 0.2492 REMARK 3 6 2.9596 - 2.7852 1.00 2815 179 0.2107 0.2876 REMARK 3 7 2.7852 - 2.6457 1.00 2784 147 0.2077 0.2589 REMARK 3 8 2.6457 - 2.5306 1.00 2852 157 0.2143 0.2264 REMARK 3 9 2.5306 - 2.4332 0.99 2802 163 0.2107 0.2432 REMARK 3 10 2.4332 - 2.3492 0.99 2783 152 0.2127 0.2409 REMARK 3 11 2.3492 - 2.2758 0.99 2806 149 0.2205 0.2679 REMARK 3 12 2.2758 - 2.2107 0.98 2753 137 0.2370 0.2755 REMARK 3 13 2.2107 - 2.1525 0.98 2799 134 0.2697 0.2977 REMARK 3 14 2.1525 - 2.1000 0.85 2398 117 0.2984 0.3318 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4576 REMARK 3 ANGLE : 0.994 6155 REMARK 3 CHIRALITY : 0.054 689 REMARK 3 PLANARITY : 0.007 759 REMARK 3 DIHEDRAL : 17.165 2747 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -0.8173 25.7103 24.3599 REMARK 3 T TENSOR REMARK 3 T11: 0.2338 T22: 0.2862 REMARK 3 T33: 0.2099 T12: -0.0018 REMARK 3 T13: -0.0032 T23: -0.0092 REMARK 3 L TENSOR REMARK 3 L11: 0.3994 L22: 0.9581 REMARK 3 L33: 0.3141 L12: 0.0900 REMARK 3 L13: -0.0414 L23: -0.2966 REMARK 3 S TENSOR REMARK 3 S11: 0.0022 S12: -0.0216 S13: 0.0000 REMARK 3 S21: -0.0404 S22: 0.0177 S23: -0.0206 REMARK 3 S31: -0.0390 S32: 0.0638 S33: -0.0168 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6A6P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1300008241. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97960 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41153 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.10240 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.0100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 5U3R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2~0.3M SODIUM FLOURIDE, 0.1M MES(PH REMARK 280 6.5), LIQUID DIFFUSION, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.87450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1820 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 229 REMARK 465 GLN A 230 REMARK 465 LEU A 231 REMARK 465 VAL A 232 REMARK 465 GLN B 230 REMARK 465 LEU B 231 REMARK 465 VAL B 232 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS B 251 H362 PE3 B 503 1.54 REMARK 500 SG CYS B 251 C36 PE3 B 503 1.77 REMARK 500 O LYS B 438 O3 B7G B 502 1.81 REMARK 500 O HOH B 658 O HOH B 692 1.82 REMARK 500 SG CYS B 251 O37 PE3 B 503 1.98 REMARK 500 NH2 ARG A 318 O HOH A 601 2.05 REMARK 500 NH1 ARG B 379 O HOH B 601 2.07 REMARK 500 OG1 THR A 280 O HOH A 602 2.10 REMARK 500 N GLY B 234 O HOH B 602 2.15 REMARK 500 O GLU B 223 O HOH B 603 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 379 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 240 172.28 174.31 REMARK 500 HIS A 389 77.27 -116.35 REMARK 500 GLU A 424 78.79 -107.89 REMARK 500 ASP A 439 75.59 66.29 REMARK 500 SER B 206 -7.25 -54.27 REMARK 500 LYS B 224 -169.13 -71.43 REMARK 500 GLU B 240 170.39 175.06 REMARK 500 HIS B 389 79.18 -115.22 REMARK 500 GLU B 424 76.21 -104.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 724 DISTANCE = 6.09 ANGSTROMS REMARK 525 HOH A 725 DISTANCE = 7.81 ANGSTROMS DBREF 6A6P A 171 440 UNP Q03181 PPARD_HUMAN 171 440 DBREF 6A6P B 171 440 UNP Q03181 PPARD_HUMAN 171 440 SEQRES 1 A 270 GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE TYR SEQRES 2 A 270 ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS LYS SEQRES 3 A 270 ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR ALA SEQRES 4 A 270 PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN ALA SEQRES 5 A 270 GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU SEQRES 6 A 270 PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR ARG SEQRES 7 A 270 CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU THR SEQRES 8 A 270 GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU PHE SEQRES 9 A 270 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS SEQRES 10 A 270 GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN LYS SEQRES 11 A 270 ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL THR SEQRES 12 A 270 ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER ASP SEQRES 13 A 270 ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN SEQRES 14 A 270 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE ILE SEQRES 15 A 270 ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU MET SEQRES 16 A 270 ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE LEU SEQRES 17 A 270 ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP SEQRES 18 A 270 ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET ALA SEQRES 19 A 270 ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET MET SEQRES 20 A 270 GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU HIS SEQRES 21 A 270 PRO LEU LEU GLN GLU ILE TYR LYS ASP MET SEQRES 1 B 270 GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE TYR SEQRES 2 B 270 ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS LYS SEQRES 3 B 270 ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR ALA SEQRES 4 B 270 PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN ALA SEQRES 5 B 270 GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU SEQRES 6 B 270 PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR ARG SEQRES 7 B 270 CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU THR SEQRES 8 B 270 GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU PHE SEQRES 9 B 270 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS SEQRES 10 B 270 GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN LYS SEQRES 11 B 270 ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL THR SEQRES 12 B 270 ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER ASP SEQRES 13 B 270 ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN SEQRES 14 B 270 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE ILE SEQRES 15 B 270 ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU MET SEQRES 16 B 270 ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE LEU SEQRES 17 B 270 ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP SEQRES 18 B 270 ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET ALA SEQRES 19 B 270 ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET MET SEQRES 20 B 270 GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU HIS SEQRES 21 B 270 PRO LEU LEU GLN GLU ILE TYR LYS ASP MET HET 9RF A 501 43 HET B7G A 502 45 HET PE3 A 503 101 HET 9RF B 501 43 HET B7G B 502 45 HET PE3 B 503 101 HETNAM 9RF {2-METHYL-4-[({5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4- HETNAM 2 9RF THIADIAZOL-2-YL}METHYL)SULFANYL]PHENOXY}ACETIC ACID HETNAM B7G HEPTYL BETA-D-GLUCOPYRANOSIDE HETNAM PE3 3,6,9,12,15,18,21,24,27,30,33,36,39- HETNAM 2 PE3 TRIDECAOXAHENTETRACONTANE-1,41-DIOL HETSYN B7G HEPTYL-BETA-D-GLUCOPYRANOSIDE; HEPTYL BETA-D-GLUCOSIDE; HETSYN 2 B7G HEPTYL D-GLUCOSIDE; HEPTYL GLUCOSIDE HETSYN PE3 POLYETHYLENE GLYCOL FORMUL 3 9RF 2(C19 H15 F3 N2 O3 S2) FORMUL 4 B7G 2(C13 H26 O6) FORMUL 5 PE3 2(C28 H58 O15) FORMUL 9 HOH *223(H2 O) HELIX 1 AA1 ALA A 173 PHE A 190 1 18 HELIX 2 AA2 THR A 193 THR A 202 1 10 HELIX 3 AA3 ASP A 215 LYS A 224 1 10 HELIX 4 AA4 GLU A 240 SER A 266 1 27 HELIX 5 AA5 ILE A 267 SER A 272 1 6 HELIX 6 AA6 PHE A 274 ALA A 295 1 22 HELIX 7 AA7 ARG A 314 SER A 319 1 6 HELIX 8 AA8 PRO A 323 ILE A 328 1 6 HELIX 9 AA9 ILE A 328 LEU A 341 1 14 HELIX 10 AB1 ASP A 344 LEU A 357 1 14 HELIX 11 AB2 ASN A 366 HIS A 389 1 24 HELIX 12 AB3 TYR A 394 GLU A 424 1 31 HELIX 13 AB4 HIS A 430 LYS A 438 1 9 HELIX 14 AB5 ASP B 174 PHE B 190 1 17 HELIX 15 AB6 THR B 193 THR B 202 1 10 HELIX 16 AB7 ASP B 215 LYS B 224 1 10 HELIX 17 AB8 GLU B 240 SER B 266 1 27 HELIX 18 AB9 ILE B 267 SER B 272 1 6 HELIX 19 AC1 PHE B 274 ALA B 295 1 22 HELIX 20 AC2 ARG B 314 SER B 319 1 6 HELIX 21 AC3 PRO B 323 ILE B 327 5 5 HELIX 22 AC4 ILE B 328 LEU B 341 1 14 HELIX 23 AC5 ASP B 344 LEU B 357 1 14 HELIX 24 AC6 ASN B 366 HIS B 389 1 24 HELIX 25 AC7 TYR B 394 GLU B 424 1 31 HELIX 26 AC8 HIS B 430 LYS B 438 1 9 SHEET 1 AA1 4 PHE A 211 ILE A 213 0 SHEET 2 AA1 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA1 4 GLY A 302 VAL A 305 -1 N LEU A 303 O VAL A 312 SHEET 4 AA1 4 VAL A 298 ASN A 299 -1 N ASN A 299 O GLY A 302 SHEET 1 AA2 4 PHE B 211 ILE B 213 0 SHEET 2 AA2 4 GLY B 310 THR B 313 1 O PHE B 311 N PHE B 211 SHEET 3 AA2 4 GLY B 302 VAL B 305 -1 N LEU B 303 O VAL B 312 SHEET 4 AA2 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 4.71 CISPEP 2 LYS B 322 PRO B 323 0 6.20 CRYST1 39.605 95.749 96.936 90.00 97.91 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025249 0.000000 0.003506 0.00000 SCALE2 0.000000 0.010444 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010415 0.00000